




Searching News Database: Antihemophilic Factor
HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
HSMN NewsFeed - 27 Dec 2016
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
Shire Announces FDA Approval of Adynovate(R) for use in Children and Surgical Settings
HSMN NewsFeed - 1 Aug 2016
Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System
Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System
HSMN NewsFeed - 24 Nov 2015
Sobi and Biogen’s ELOCTA(R) (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
Sobi and Biogen’s ELOCTA(R) (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
HSMN NewsFeed - 15 Sep 2015
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
HSMN NewsFeed - 9 Aug 2010
Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A
Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A
HSMN NewsFeed - 29 Jun 2007
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
HSMN NewsFeed - 1 Feb 2007
Grifols Announces FDA Approval of Alphanate(R) to Treat von Willebrand Disease
Grifols Announces FDA Approval of Alphanate(R) to Treat von Willebrand Disease
HSMN NewsFeed - 11 Oct 2006
Baxter Announces Launch of BAXJECT(R) II Needle-Less Transfer Device for ADVATE(R)
Baxter Announces Launch of BAXJECT(R) II Needle-Less Transfer Device for ADVATE(R)
HSMN NewsFeed - 17 Jul 2006
Bayer HealthCare Introduces Free Product Trial Program For Kogenate(R) FS with BIO-SET(R)
Bayer HealthCare Introduces Free Product Trial Program For Kogenate(R) FS with BIO-SET(R)
HSMN NewsFeed - 9 May 2006
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
Additional items found! 24

Members Archive contains
24 additional stories matching:
Antihemophilic Factor
(Password required)
Antihemophilic Factor
(Password required)